Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group

Neurology
R G MillerM A Ross

Abstract

We designed a phase II trial to evaluate the efficacy of gabapentin in slowing the rate of decline in muscle strength of patients with amyotrophic lateral sclerosis (ALS) and to assess safety and tolerability. Gabapentin (800 mg) or placebo was administered t.i.d. in a randomized, double-blinded, placebo-controlled, trial for 6 months. We enrolled 152 patients at eight sites in the United States. The primary outcome measure was the slope of the arm megascore, the average maximum voluntary isometric strength from eight arm muscles standardized against a reference ALS population. A secondary outcome measure was forced vital capacity. Slopes of arm megascores for patients on gabapentin were compared with slopes of those taking placebo using a two-way ANOVA. We observed a nonstatistically significant trend (p = 0.057-0.08) toward slower decline of arm strength in patients taking gabapentin compared with those taking placebo (mean difference 24%, median 37%). We observed no treatment effect on forced vital capacity. Gabapentin was well tolerated by patients with ALS. These results suggest that further studies of gabapentin in ALS are warranted.

Citations

Apr 3, 1999·Medicinal Research Reviews·J S Bryans, D J Wustrow
Oct 4, 2002·Muscle & Nerve·P L McGeer, E G McGeer
Feb 24, 2001·Journal of Neurology·A C Ludolph
Nov 30, 2000·Current Treatment Options in Neurology·B M Demaerschalk, M J Strong
Feb 13, 2009·Current Treatment Options in Neurology·Barrington G BurnettCharlotte J Sumner
Nov 21, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Swati Aggarwal, Merit Cudkowicz
Nov 25, 2000·Journal of the Neurological Sciences·O Hurko, F S Walsh
Oct 26, 2001·Journal of the Neurological Sciences·R G MillerUNKNOWN SMA Study Group
Jan 7, 1998·Journal of the Neurological Sciences·G D Borasio
Dec 16, 1998·Journal of the Neurological Sciences·L MazziniE Pastore
Aug 17, 1999·Journal of the Neurological Sciences·S KalraN R Cashman
Jun 5, 2003·Pharmacology & Therapeutics·Michael J Strong
Jun 1, 1997·Trends in Pharmacological Sciences·E LouvelA Doble
Apr 29, 1998·Epilepsy Research·C P TaylorL Singh
Nov 6, 2002·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Giampietro ZanetteNicola Rizzuto
Jun 18, 2002·Acta Neurologica Scandinavica·I Niebroj-DoboszH Kwieciński
Jul 23, 1999·Acta Neurologica Scandinavica·I Niebroj-Dobosz, P Janik
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Merit CudkowiczJeremy Shefner
Jul 26, 2012·Neurology Research International·Kalina Venkova-HristovaKenneth Hensley
Jan 5, 2002·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·M J Strong
May 1, 1997·Clinical Therapeutics·M K Bazil, C W Bazil
Dec 8, 2009·Neuropsychiatric Disease and Treatment·Stefano ZoccolellaPaolo Lamberti
Mar 8, 2006·Journal of Herbal Pharmacotherapy·Orly Vardeny, Mark B Bromberg
Jul 5, 2005·Expert Opinion on Investigational Drugs·E C Lai
Nov 30, 2004·Expert Opinion on Investigational Drugs·Michael J Strong
Jul 5, 2005·Expert Opinion on Investigational Drugs·M B Bromberg
Aug 3, 2011·Expert Opinion on Emerging Drugs·Ali Aamer Habib, Hiroshi Mitsumoto
Feb 7, 2012·Expert Opinion on Investigational Drugs·John A Morren, Nestor Galvez-Jimenez
Jun 25, 2008·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Veena Lanka, Merit Cudkowicz
Dec 2, 2005·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·Mamede de CarvalhoMichael Swash
Sep 30, 2008·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Richard S BedlackDebra Heydt
Mar 17, 2007·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Petra KaufmannUNKNOWN QALS study group
Nov 20, 2009·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Muddasir QureshiMerit E Cudkowicz
Jun 30, 2009·Experimental Neurology·Jeremy M Shefner
Apr 28, 2009·Progress in Neurobiology·Ivona BrasnjevicUNKNOWN European NanoBioPharmaceutics Research Initiative
Jul 16, 2008·Physical Medicine and Rehabilitation Clinics of North America·Jeremy M Shefner
Dec 1, 2015·Neurodegenerative Disease Management·Rosemary ClarkTracey Dickson
Feb 23, 2008·Experimental Neurology·L Van Den Bosch, W Robberecht
Apr 1, 2003·Annals of Neurology·G J GroeneveldLeonard H van den Berg
Nov 18, 2005·Journal of Clinical Pharmacology·Rabia B Choudry, Merit E Cudkowicz
Sep 4, 2015·Muscle & Nerve·James B CaressMichael S Cartwright
Aug 24, 1999·Archives of Physical Medicine and Rehabilitation·K FrancisJ A DeLisa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.